Epithalon Research for Anti-Aging
An evidence-based overview of research examining Epithalon in the context of anti-aging. This page synthesizes findings from peer-reviewed literature.
Research Summary
Epithalon is marketed primarily for anti-aging based on claimed telomerase activation and lifespan extension in animal models. Russian research reports prolonged lifespan in mice and fruit flies and extended cellular replicative capacity via telomerase activation and telomere elongation in human fetal fibroblasts. A 2025 independent cell-line study reported telomere-related changes; its telomere, telomerase and ALT figures were replaced in a published correction. No controlled human clinical trials have evaluated anti-aging outcomes.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.